Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Cuppens, Tine"'
Autor:
Croce, Sabrina 1, 2, Ducoulombier, Agnès 3, 4, Ribeiro, Agnès 1, Lesluyes, Tom 2, 5, Noel, Jean-Christophe 6, Amant, Frédéric 7, 22, 8, Guillou, Louis 9, 10, Stoeckle, Eberhard 11, Devouassoux-Shisheboran, Mojgan 12, Penel, Nicolas 3, Floquet, Anne 13, Arnould, Laurent 14, Guyon, Frédéric 11, Mishellany, Florence 15, Chakiba, Camille 13, Cuppens, Tine 7, 22, Zikan, Michal 16, Leroux, Agnès 17, Frouin, Eric 18, Farre, Isabelle 19, Genestie, Catherine 20, Valo, Isabelle 21, MacGrogan, Gaëtan 1, Chibon, Frédéric 1, 2
Publikováno v:
In Modern Pathology May 2018 31(5):816-828
Autor:
Cuppens, Tine, Depreeuw, Jeroen, Annibali, Daniela, Thomas, Debby, Hermans, Els, Gommé, Ellen, Trinh, Xuan Bich, Debruyne, David, Moerman, Philippe, Lambrechts, Diether, Amant, Frédéric
Publikováno v:
In Gynecologic Oncology September 2017 146(3):538-545
Autor:
Croce, Sabrina, Ribeiro, Agnes, Brulard, Celine, Noel, Jean-Christophe, Amant, Frederic, Stoeckle, Eberhard, Devouassoux-Shisheborah, Mojgan, Floquet, Anne, Arnould, Laurent, Guyon, Frederic, Mishellany, Florence, Garbay, Delphine, Cuppens, Tine, Zikan, Michal, Leroux, Agnès, Frouin, Eric, Duvillard, Pierre, Terrier, Philippe, Farre, Isabelle, Valo, Isabelle, MacGrogan, Gaetan M, Chibon, Frederic
Publikováno v:
In Modern Pathology July 2015 28(7):1001-1010
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cuppens, Tine, Moisse, Matthieu, Depreeuw, Jeroen, Annibali, Daniela, Colas, Eva, Gil-Moreno, Antonio, Huvila, Jutta, Carpén, Olli, Zikán, Michal, Matias-Guiu, Xavier, Moerman, Philippe, Croce, Sabrina, Lambrechts, Diether, Amant, Frédéric
Publikováno v:
International journal of cancer. Journal international du cancer, 142(6), 1230-1243. Wiley-Liss Inc.
Uterine leiomyosarcomas (uLMS) are rare, aggressive malignancies for which limited treatment options are available. To gain novel molecular insights into uLMS and identify potential novel therapeutic targets, we characterized 84 uLMS samples for geno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::63ac09d7b011eef5b4fe953f29d8bdb6
https://pure.amc.nl/en/publications/integrated-genome-analysis-of-uterine-leiomyosarcoma-to-identify-novel-driver-genes-and-targetable-pathways(70ec300f-14b4-41ba-b5b4-35254c52bd00).html
https://pure.amc.nl/en/publications/integrated-genome-analysis-of-uterine-leiomyosarcoma-to-identify-novel-driver-genes-and-targetable-pathways(70ec300f-14b4-41ba-b5b4-35254c52bd00).html
Publikováno v:
Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine; May 2021, Vol. 76 Issue: 3 p224-231, 8p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cuppens T; Department of Oncology, Gynecologic Oncology, KU Leuven (University of Leuven), Leuven, 3000, Belgium.; VIB Center for Cancer Biology, VIB, Leuven, Belgium., Moisse M; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium., Depreeuw J; Department of Oncology, Gynecologic Oncology, KU Leuven (University of Leuven), Leuven, 3000, Belgium.; VIB Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium., Annibali D; Department of Oncology, Gynecologic Oncology, KU Leuven (University of Leuven), Leuven, 3000, Belgium., Colas E; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain., Gil-Moreno A; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.; Gynecological Oncology Department, Vall Hebron University Hospital, Barcelona, Spain., Huvila J; Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland., Carpén O; Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland.; Department of Pathology and Genome Scale Research Program, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland., Zikán M; Department of Obstetrics and Gynecology, Gynecological Oncology Center, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic., Matias-Guiu X; Pathological Oncology Group and Pathology Department, Hospital U Arnau de Vilanova, and Hospital U de Bellvitge, IRBLLEIDA and Idibell, University of Lleida, CIBERONC, Lleida, Spain., Moerman P; Department of Pathology, UZ Leuven - KU Leuven (University of Leuven), Leuven, B-3000, Belgium., Croce S; Department of Biopathology, Institut Bergonié, Bordeaux, F-33000, France., Lambrechts D; VIB Center for Cancer Biology, VIB, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium., Amant F; Department of Oncology, Gynecologic Oncology, KU Leuven (University of Leuven), Leuven, 3000, Belgium.; Centre for Gynecologic Oncology Amsterdam (CGOA), Antoni Van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2018 Mar 15; Vol. 142 (6), pp. 1230-1243. Date of Electronic Publication: 2017 Nov 07.